Tuesday, September 16, 2025

Aurora Cannabis Sees Product Approved For Irish Market

Aurora Cannabis (TSX: ACB) (NYSE: ACB) announced this morning that the firm has expanded its international market exposure to that of Ireland. The firm recently saw one of its oil products approved for import to the European country.

Ireland recently implemented a new Medical Cannabis Access Programme (MCAP), which is slated to run for five years following legislation that was signed into law in June 2019 by the Minister of Health. The approval for medical cannabis is currently limited to a narrow set of medical conditions which include spasticity associated with multiple sclerosis, nausea associated with chemotherapy, and severe epilepsy.

Aurora’s High CBD Oil Drops product is the second product to be approved for importation, prescription, and supply under the new legislation, following Tilray’s approval this past summer. Tilray Inc (NASDAQ: TLRY) shipped an undisclosed amount of cannabis oil to Ireland for use in the MCAP program back in early July, following the initial approval of the program by the health minister.

Aurora did not disclose when the first shipment of CBD oil will be made to the European nation, or what quantities are expected to be exported.

Aurora Cannabis closed Friday’s session at $2.50 on the New York Stock Exchange.


Information for this briefing was found via Sedar and Aurora Cannabis. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

New Found Gold: The Strategic Maritime Resources Purchase

Amex Exploration: Revised Perron PEA Has INSANE Economics

Aris Mining: The Multi Billion Dollar Soto Norte PFS

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

Aurora Cannabis Lists Sun Facility For Sale With Colliers

Aurora Cannabis (TSX: ACB) (NYSE: ACB) has placed its Aurora Sun facility, located in Medicine...

Friday, March 12, 2021, 10:31:43 AM

Aurora Cannabis: Canaccord Cuts Price Target, Lowers 2022 Estimates

On September 27, Aurora Cannabis (TSX: ACB) reported its fiscal fourth quarter results. The companies...

Wednesday, September 29, 2021, 09:42:00 AM

Aurora Cannabis: Canaccord Anticipates Q2 Revenues Of $69.5 Million

On Thursday, February 11th, Aurora Cannabis (TSX: ACB) (NYSE: ACB) is scheduled to release their...

Tuesday, February 9, 2021, 04:01:00 PM

Aurora Cannabis: Analysts Slash Price Targets Ahead Of Q4 Earnings

Tomorrow after market close Aurora Cannabis (TSX: ACB) (NYSE: ACB) will be reporting their fiscal...

Monday, September 21, 2020, 03:15:54 PM

Aurora Cannabis’ Revenues Fall 6% To $67.8 Million In Q1 2021, Net Loss Hits $109.5 Million

Whereas Canopy Growth Corp (TSX: WEED) (NYSE: CGC) posted revenue growth of 22.5% this morning...

Monday, November 9, 2020, 07:37:06 AM